Ribociclib combined with endocrine therapy is usually reserved for postmenopausal women. Researchers looked at whether it can also help premenopausal women. Between 20-50% of all breast cancers worldwide are diagnosed in women under 50 years old. Doctors have prescribed different drugs and different endocrine therapy protocols for premenopausal breast cancer patients compared with postmenopausal breast […]

The post Phase 3 trial finds Ribociclib an effective treatment for premenopausal breast cancer appeared first on Medical News Bulletin.

A new test could eventually help patients to avoid unnecessary surgery for ductal carcinoma in situ (DCIS), according to University of California San Diego scientists. In a research article published in Cell Reports, the La Jolla located bioengineers report that they can predict how likely a tumour is to progress to cancer based on how […]

The post Sticking It to Ductal Carcinoma In Situ appeared first on Medical News Bulletin.

Breast cancer is the most common cancer in women in the United States after skin cancer. According to the American Cancer Society, one in eight women will be diagnosed with breast cancer in their lifetime.  Breast Cancer Awareness Month highlights the importance of timely diagnosis, it is a time to hail the survivors of breast […]

The post Breast Cancer Awareness Month 2023: Strength in Numbers appeared first on Medical News Bulletin.

A recent study investigated whether anastrozole treatment could reduce the risk of breast cancer recurrence. Estrogen hormone promotes the growth and survival of normal and cancerous breast epithelial cells. Some breast cancers are more sensitive to the hormone estrogen, and they are known as estrogen receptor (ER)-positive breast cancers. Anastrozole is in a class of […]

The post Long-term follow-up supports anastrozole treatment for prevention of breast cancer recurrence appeared first on Medical News Bulletin.

A recent study has investigated whether levels of specific immune cells like leukocytes could predict breast cancer risk. A leukocyte is a white blood cell of the immune system that protects the body against infectious disease and is produced in the bone marrow. There are several sub-types of leukocytes, among them are monocytes and B […]

The post Immune Cells As Biomarkers to Detect Risks for Breast Cancer appeared first on Medical News Bulletin.

Researchers at Lancaster University recently studied whether eating yogurt may lessen the risk of breast cancer. In the United States, breast cancer is the most common cancer among women. While the rate of breast cancer deaths has gradually decreased since 1999, in 2016 the death rate was 20 deaths per 100,000 women. That equaled to […]

The post Can eating yogurt prevent breast cancer? appeared first on Medical News Bulletin.

A recent study evaluated the effect of lactate on breast cancer cells and how this may contribute to cancer formation. Why does cancer need glucose? Cancer cells consume increased amounts of glucose, a simple sugar molecule. Cancer cells also produce an increased amount of lactate, a byproduct of glucose. Glucose plays a key role in […]

The post Glucose metabolite fuels breast cancer appeared first on Medical News Bulletin.

High energy stores of glycogen found in cancer cells may be contributing to the aggressive spread of breast cancer. More than fifty percent of solid tumours have regions of hypoxia (i.e., areas receiving inadequate levels of oxygen), which have been associated with metastasis (the spread of cancer) and poorer outcomes in many types of cancers, […]

The post The spread of breast cancer is aided by its ability to store and use energy appeared first on Medical News Bulletin.